Associate Director, Clinical Biomarkers

Role Summary

The Associate Director of Clinical Biomarkers will play a pivotal role in advancing biomarker strategies to support the clinical development of Nurix’s innovative therapies targeting protein homeostasis. As a leader in the Clinical Biomarkers team, the successful candidate will collaborate across research, clinical development, and external partnerships to drive the biomarker strategy for early phase clinical trials. This role involves leading the design, execution, and interpretation of biomarker assays, contributing to patient selection, pharmacodynamic assessments, and the elucidation of drug mechanisms of action.

Location:

Brisbane, CA - Onsite.

• Lead the development, validation, and execution of clinical biomarker strategies to inform patient stratification, response prediction, and resistance mechanisms across Nurix’s clinical programs.
• Leverage deep expertise in cell and tumor biology, molecular biology, inflammation and immuno-oncology to design and interpret both preclinical and clinical biomarker studies.
• Oversee biomarker assay development, including assay qualification and execution on diverse platforms, to support pharmacodynamic and predictive biomarker analysis in clinical trials.
• Lead the evaluation and implementation of novel biomarker assays in both nonclinical models and patient-derived samples, ensuring alignment with clinical trial objectives.
• Collaborate closely with multidisciplinary teams, including research scientists, clinical development, external collaborators, and contract research organizations (CROs), to ensure seamless integration of biomarker data into clinical development plans.
• Provide scientific and strategic input into clinical trial designs, ensuring biomarker data are effectively utilized to guide therapeutic decisions and optimize patient outcomes.
• Mentor and manage junior scientists, fostering a collaborative and innovative research environment.
• Demonstrate strong motivation, creativity, and teamwork, with excellent time management and organizational skills.

• Preferred:
  Advanced degree (M.S, Ph.D. preferred) with 8+ years of experience in a relevant scientific area within the pharmaceutical or biotech industry; candidates with a strong translational biomarker background in Immunology, Oncology, or Hematology are preferred.
• Proven expertise in the development, qualification, and implementation of clinical biomarker assays, particularly in the areas of inflammation, immuno-oncology, cancer biology, or related therapeutic areas.
• Extensive technical experience across diverse platforms, including flow cytometry, molecular biology, proteomics, and tissue-based assays; hands-on experience with clinical samples is a plus.
• Demonstrated leadership in cross-functional teams, with a track record of integrating biomarker data to influence clinical decision-making.
• Strong organizational and project management skills, with the ability to lead multiple projects simultaneously in a fast-paced environment.
• Excellent communication and interpersonal skills, with the ability to present complex biomarker data to both scientific and clinical audiences, as well as external stakeholders.
• Innovative mindset with a proactive approach to problem-solving and a strong motivation to drive scientific excellence in biomarker research.

• Scientific leadership and cross-functional collaboration
• Biomarker assay development and data interpretation
• Strong communication and presentation of complex data
• Project management and multitasking in a fast-paced environment

• Advanced degree (M.S, Ph.D. preferred) in a relevant scientific field